Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

6.93

-0.31 (-4.28%)

At close: Feb 11, 2026, 4:00 PM EST

6.75

-0.18 (-2.60%)

After-hours: Feb 11, 2026, 7:54 PM EST

Revenue by Product

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Precision Medicine	771.11M
Therapeutics	9.35M
Manufacturing Solutions	2.75M

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	762.31M
United States Growth	55.68%
Other Countries	16.01M
Other Countries Growth	242.94%
Canada	2.54M
Australia	1.22M
Australia Growth	4.63%
United Kingdom	579.00K
United Kingdom Growth	-55.67%
Belgium	546.00K
Belgium Growth	19.21%